A multi-nutrient supplement reduced markers of inflammation and improved physical performance in active individuals of middle to older age: a randomized, double-blind, placebo-controlled study by Dunn-Lewis, Courtenay et al.
RESEARCH Open Access
A multi-nutrient supplement reduced markers of
inflammation and improved physical performance
in active individuals of middle to older age: a
randomized, double-blind, placebo-controlled study
Courtenay Dunn-Lewis, William J Kraemer
*, Brian R Kupchak, Neil A Kelly, Brent A Creighton, Hui-Ying Luk,
Kevin D Ballard, Brett A Comstock, Tunde K Szivak, David R Hooper, Craig R Denegar and Jeff S Volek
Abstract
Background: While exercise acts to combat inflammation and aging, the ability to exercise may itself be
compromised by inflammation and inflammation’s impact on muscle recovery and joint inflammation. A number
of nutritional supplements have been shown to reduce inflammation and improve recovery. The purpose of the
current investigation was to examine the effect of a multi-nutrient supplement containing branched chain amino
acids, taurine, anti-inflammatory plant extracts, and B vitamins on inflammatory status, endothelial function, physical
function, and mood in middle-aged individuals.
Methods: Thirty-one healthy and active men (N = 16, mean age 56 ± 6.0 yrs) and women (N = 15, mean age =
52 ± 7.5 yrs) participated in this investigation. Subjects completed one 28 day cycle of placebo supplementation
and one 28 day cycle of multi-nutrient supplementation (separated by a one week washout period) in a balanced,
randomized, double-blind, cross-over design. Subjects completed weekly perceptual logs (PROMIS-57, KOOS) and
pre- and post- testing around the supplementation period. Testing consisted of brachial artery flow mediated
dilation (FMD), blood measures, and physical performance on vertical jump, handgrip strength, and balance
(dispersion from center of pressure). Significance for the investigation was p ≤ 0.05.
Results: IL-6 significantly decreased in both men (from 1.2 ± 0.2 to 0.7 ± 0.4 pg·mL
-1) and women (from 1.16 ±
0.04 to 0.7 ± 0.4 pg·mL
-1). Perceived energy also improved for both men (placebo: 1.8 ± 0.7; supplement: 3.7 ± 0.8
AUC) and women (placebo: 1.2 ± 0.7; supplement: 2.8 ± 0.8 AUC). Alpha-1-antichymotrypsin (from 108.9 ± 38.6 to
55.5 ± 22.2 ug·mL
-1), Creatine Kinase (from 96 ± 34 to 67 ± 23 IU·L
-1), general pain, and joint pain decreased in
men only, while anxiety and balance (from 0.52 ± 0.13 to 0.45 ± 0.12 cm) improved in women only. Men showed
increased performance in vertical jump power (from 2642 ± 244 to 3134 ± 282 W) and grip strength (from 42.1 ±
5.9 to 48.5 ± 4.9 kg).
Conclusions: A multi-nutrient supplement is effective in improving inflammatory status in both men and women,
markers of pain, joint pain, strength, and power in men only, and both anxiety and balance (a risk factor for hip
fracture) in women. Therefore, a multi-nutrient supplement may help middle-aged individuals to prolong physical
function and maintain a healthy, active lifestyle.
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Aging has long been portrayed as an unpredictable,
indiscriminate process of degeneration in cognitive and
physical function. This harsh view has been challenged
by our modern understanding of the role that age-
related increases in inflammation play in chronic disease
and aging [1]. It now appears that physiological well-
being at advanced age may be influenced by the every-
day anti-inflammatory habits of the individual [2]. Sim-
ple lifestyle choices, such as physical exercise and
dietary patterns, may address chronic systemic inflam-
mation and improve long-term health and function
[3,4]. We now appreciate that inflammatory cytokines
may be influenced by habitual behavior; this includes
Interleukin-6 (IL-6), an inflammatory cytokine strongly
associated with cognitive impairment [5], functional
decline, loss of strength, sarcopenia, and mortality [6].
Indeed, exercise and nutrition may attenuate even the
processes of aging that were once considered inevitable,
such as declines in cognitive function, mood, sarcopenia,
quality of life [7]. Our modern concept therefore sug-
gests that although the processes of aging and inflam-
mation certainly cannot be halted, it may be possible to
extend cognitive and physical function long-term
through appropriate diet and exercise practices.
While exercise acts as an important anti-inflammatory
aid, the ability to recover from exercise in and of itself
may be subject to the challenges of age-related inflam-
mation. Aging is accompanied by increased free radical
formation and circulatory changes that exacerbate
inflammatory processes. This inflammatory cascade may
include an increase in IL-6 - ordinarily an important
component of muscle hypertrophy, but an inhibitor of
muscle recovery at elevated concentrations [8]. IL-6 pro-
motes chronic inflammation [9] and plays a large role in
joint inflammation [10,11]. IL-6 contributes to the pro-
duction of ACT [12] and together, the two inflammatory
markers are associated with a two- to three-fold risk of
reduced muscle strength in older adults [13]. At the
same time, upstream hormonal signal processes, which
are vital in gene expression and protein synthesis for
both contractile and non-contractile proteins in skeletal
muscle, also decline with age. The recovery of muscle
and tissue slows with age, repair and remodeling of
muscle is compromised, and inflammatory joint pain
may persist (even in the absence of rheumatoid arthri-
tis). Osteoporosis becomes a increasing concern, parti-
cularly in women; with age, the incidence of falling and
the severity of fall-related injury increases dramatically,
resulting in increased nursing home admissions [14] and
hip fractures that significantly increase risk of mortality
[15]. Furthermore, vascular endothelial dysfunction (as
demonstrated by reduced brachial artery flow mediated
dilation (FMD)) has been reported in healthy, sedentary
middle-aged and older adults [16,17], and is regarded as
an early manifestation of CVD [18]. Brachial artery
FMD is inversely related to plasma markers of inflam-
mation [19] and inflammation-induced oxidative stress
potentially mediates endothelial dysfunction [20] in mid-
dle-aged and older adults (thus interventions that
improve endothelial homeostasis may have important
clinical implications to reduce CVD-related morbidity
and mortality). Combined, these factors result in pro-
gressive functional limitations and disability. As such,
while exercise is an important factor in fighting inflam-
mation, aging individuals may need additional nutri-
tional support to combat the effect of inflammation on
the body, improve recovery from and adaptation to
exercise, and therefore permit them to remain physically
active with age.
Given the importance of chronic inflammation and
recovery to health, a number of studies have found that
certain nutritional supplements, in combination with a
healthy, balanced diet and exercise, may allow for
improved recovery and anti-inflammatory action [21].
Branched chain amino acids (BCAA), for example, have
analgesic properties [22] and may inhibit the breakdown
of muscle protein and enhance muscle protein synthesis
[23]; this has been particularly shown with leucine sup-
plementation [24]. Taurine, also amino acid, acts as a
powerful anti-inflammatory that may reduce IL-6 pro-
duction [25]. Green tea, a source of polyphenols, has
chelating [26], anti-inflammatory, antibacterial, anti-
mutagenic, anti-diabetic, and hypocholesterolemic prop-
erties [27]. It may help in cancer prevention, weight loss
or management, stroke prevention, and prevention of
cardiovascular disease [28]. Quercetin, another anti-
inflammatory aid [29], may inhibit mast cell activation
[30], serve as a psychostimulant, and improve physiolo-
gical performance, health, and disease resistance [31].
Cat’sc l a wo runcaria tomentosa, a wood-like vine, is
another powerful antioxidant and anti-inflammatory
[32]. In a separate role, B-vitamins have limited anti-
inflammatory properties but are cofactors, crucial in
metabolism, may increase energy (especially if diet is
poor), and may improve mood and stress [33,34]. There-
fore, a number of substances exist that improve age-
related recovery and inflammation in distinct and inde-
pendent ways.
While each of the nutritional substances noted impart
powerful physiological effects, each act independently
and individually lacks the benefits that others may pos-
sess. Thus, the multifaceted impact of inflammation and
aging on exercise performance may benefit from a mul-
tidimensional supplement that includes each of these
substances in a single supplement. Although the ingredi-
ents independently have been shown to contribute to
amino acid signaling, reduction of inflammation, and
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plement would benefit recovery, joint health, remodeling
of muscle, and energy in healthy individuals attempting
to remain physically active. Therefore, the purpose of
t h i ss t u d yi st oe x a m i n et h ee f f e c t so fam u l t i - n u t r i e n t
supplement on physical performance, endothelial func-
tion, fatigue, mood, and other recovery factors in active
men and women from the ages 40-70 years.
Methods
Experimental Design
This investigation utilized a balanced, cross-over, within-
group, placebo-controlled design to examine the effects
of the multi-nutrient supplement (BioCharge
®,A d v o -
care, Plano, TX; please see Table 1 for ingredients) on
physical performance, joint health, fatigue, mood, and
inflammation during the recovery period of active sub-
jects. (The placebo included the same natural raspberry
flavor, sucralose, and natural beet-derived color that
matched the natural form and color of the active sup-
plement). As seen in Figure 1, the study consisted of
two cycles (one cycle of BioCharge
®, one of placebo, the
order randomly assigned in a balanced fashion). The
funding agency blinded the supplement and placebo (as
A and B). No indication of this assignment was provided
(either on the packaging or otherwise) to any member of
the study staff or any subject until after data collection
and analysis had ceased. Each cycle required four weeks
(28 days) of supplementation between its first and last
v i s i ta tw h i c ht i m es u b j e c ts mixed one packet of the
powdered supplement or an identical but otherwise
inactive placebo each day with 4-8 ounces of water.
Between the two cycles there was a washout period of
at least one week and subjects were asked to maintain
the same level of activity between both cycles (as veri-
fied by activity questionnaire). The four testing visits
occurred immediately before and immediately following
the supplementation period. Testing consisted of assess-
ment of endothelial function via high-resolution ultraso-
nography, blood draws, and physical tests (handgrip,
quiet standing, and vertical jumps). In addition, at the
end of each week of each supplementation cycle, sub-
jects filled out a logbook at home. Registered dieticians
ensured compliance to supplement protocol and daily
consumption.
Subjects
Thirty-one healthy and recreationally active subjects
participated in this investigation (16 men and 15
women). Subject characteristics were (Mean ± SD), men
(n = 16): age, 56.0 ± 6.0 yrs, height, 177.3 ± 3.8 cm,
body mass, 85.3 ± 8.9 kg; women (n = 15): age, 52.0 ±
7.5 yrs, height, 168.4.3 ± 4.2 cm, body mass, 75.5 ± 10.7
kg. Subjects were recreationally active (expending
Table 1 Ingredients of Biocharge
® supplement
Supplement Facts
Serving Size: 1 packet added to water
Servings Per Container: 14 packets per carton
Amt Per
Serving
%DV
B Vitamins
Vitamin B12 0.25 mg 4200%
Vitamin B6 6 mg 300%
Folic acid (Vitamin B9) 0.40 mg 100%
Pantothenic Acid (Vitamin B5) 20 mg 200%
Amino Acids
Taurine 500 mg *
1-Leucine 2000 mg *
Isoleucine 500 mg *
Valine 500 mg *
Plant Extracts
Cat’s Claw (uncaria tomentosa) 100 mg *
Quercitin 100 mg *
Green tea 50 mg *
Biovin grape extract (full spectrum whole grape extract).
Contains Proanthocyanidins (OPC), Polyphenols, and Trans-resverattrol
25 mg *
*Daily Value (DV) not established
Other ingredients: natural and artificial flavor, citric acid, sucralose. The supplement is comprised of food-grade ingredients. It contains ingredients that the FDA
has either approved as food additives or considers “generally recognized as safe”.
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ous activity accounting for approximately 2080 ± 2300
METS per week) and participated in various activities
(none were trained master athletes).
Our medical monitor screened subjects for pre-exist-
ing medical conditions that could put subjects at risk or
interfere with the investigation. Exclusion criteria
included, but were not limited to: heart conditions or
anomalies; respiratory conditions; blood pressure pro-
blems; and musculoskeletal problems or previous ortho-
pedic injuries that would limit the range of motion. In
addition, participants were excluded if they had recently
taken or planned to take any products containing crea-
tine, ephedra, and high doses of caffeine. All subjects
were fully informed of the protocol design and asso-
ciated risks of this investigation before signing an
informed consent approved by the University of Con-
necticut Institutional Review Board for use of human
subjects.
Procedures
Treatment conditions Subjects were asked to continue
their normal workouts during the study and maintain
the same level of activity between both cycles. To ensure
consistency of their daily activities during the two sup-
plementation periods, subjects were asked to fill out the
logbook which included a physical activity report and a
medication treatment log for the end of each week. Sub-
jects were asked to fast (other than water as subjects
were instructed on hydration protocols with urine speci-
fic gravity used for verification) for 12 hours prior to
the lab visit. Exercise was not permitted 24 hours prior
to visits and all visits occurred in the morning and
within a one-hour window of their first visit.
Flow Mediated Dilation Endothelium-dependent FMD
was assessed non-invasively in the peripheral circulation
using high-frequency ultrasonographic imaging (Acuson
C o r p ,E l m w o o d )P a r k ,N J )a te a c ht e s t i n gv i s i ta s
described [35] with minor modification. Briefly, brachial
artery FMD was measured following a 5 min occlusion
of the forearm as this method is suggested to better
reflect nitric oxide (NO˙)-mediated vascular dilation
compared to upper arm occlusion [36]. All vascular
measurements and analysis were performed by two
trained investigators in a blinded manner. Relative (%)
and absolute (mm) FMD were calculated by determining
peak post-occlusion vessel diameter relative to pre-
occlusion diameter.
Biochemical Sampling and Analyses At each blood
draw, 20 ml of blood was collected from the antecubital
vein via venipuncture into tubes containing either no
preservative (Serum) or EDTA. Tubes were centrifuged
at 3000 RPM for 15 min at 4°c. Serum/plasma was
transferred into storage tubes and stored at -80°C for
future analysis.
As a measure of tissue disruption and recovery status,
Creatine Kinase concentration was measured in dupli-
cate using Diagnostics Chemicals Limited (Oxford, CT)
reagents. Glucose (for confirmation of fasting) and C-
reactive protein (CRP) (a measure of local inflammation)
were determined using a Cobas c 111 automated analy-
zer (Roche Diagnostics, Indianapolis, IN). Glucose and
CRP reagents were purchased from Fisher Scientific. IL-
6 was determined using the Invitrogen Corporation
(Carmarillo, CA) ultrasensitive ELISA. Cortisol was ana-
lyzed with the ALPCO Diagnostics (Salem, NH) ELISA
to confirm abstinence from exercise and healthy popula-
tion status. The Immunology Consultants Laboratory,
Inc. (Newberg, OR) ELISA was used to determine alpha
1 -antichromotrypsin. All ELISAs were performed on
the Molecular Devices VERSAmax tunable microplate
Figure 1 Experimental Design. Participants were randomly assigned to begin with either the multi-nutrient supplement or placebo
supplement to begin in a balanced fashion. After a wash-out period, subjects completed the opposite supplement. Testing occurred
immediately prior to and immediately following the 28-day supplementation periods.
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5%.
Physical Performance Testing Subjects performed a
stationary standing test on a force platform (Advanced
Mechanical Technology, Inc., Watertown, MA) to exam-
ine balance as determined by dispersion from center of
pressure [37]. They were instructed to stand with feet
together and arms relaxed and to the side for 40 sec-
onds. A countermovement vertical jump test was also
performed on the force platform to determine muscle
function and power capabilities [38]. Subjects initiated
three maximal effort countermovement vertical jumps
on a force plate (with their hands on their waists during
the movement). In addition, subjects performed a maxi-
mal isometric handgrip strength test [39]. The hand grip
was held by their side with their dominate hand. Sub-
jects were asked to squeeze the handgrip instrument as
hard and as quickly as possible for approximately 2-4
seconds with a two minute rest period between each
repetition. Three trials were performed and the best
score was recorded.
Perceptual Scales The Logbook utilized the National
Institutes of Health PROMIS-57 Assessment Center
scales for functioning [40], the Lequesne Knee Index [41]
and the Knee Injury and Osteoarthritis Outcome Score
(KOOS)[40,42]. We examined PROMIS-57 subscales of
physical function, mood (anxiety), fatigue, and pain. The
Lequesne index is a 10-question survey given to indivi-
duals with osteoarthritis of the knee accessing pain or
discomfort, walking, and activities of daily living. The
KOOS consists of 5 subscales: Pain, Symptoms, Function
in Daily Living, Function in Sport and Recreation and
Knee-Related Quality of life. Perceived energy was
adapted from the Multidimensional Fatigue Symptom
Inventory-Short Form (MFSI-SF)[43] and reported at the
final visit of each cycle using a 5-point Likert scale.
Statistical Analyses The data are presented as means
and standard deviations. Area under the curve calcula-
tions for blood markers using the trapezoidal method
were also calculated for selected variables. Data were
evaluated for assumptions for use of linear analysis mod-
els before analysis and then corrected with log10 trans-
formations and reanalyzed when appropriate. A two-way
analysis of variance was used to examine changes in the
distribution. Where significant main effects were deter-
mined, an appropriate Tukey’so rF i s h e r ’sL S Dp o s th o c
test were conducted to determine pairwise differences
between treatments of sex. Intra-class correlation coeffi-
cients were all R ≥ 0.94. The alpha level for significance
in this investigatgion was be set at P ≤ 0.05.
Results
The supplement was well-tolerated by all subjects, both
in terms of taste and absence of any side effects. No
significant differences were shown between the pre- and
post- placebo testing conditions for any variables. In
addition, as applicable, no significant differences were
seen between placebo and testing variables prior to
supplementation.
Men displayed a significant decrease in IL-6 (from 1.2
± 0.2 to 0.7 ± 0.4 pg·mL
-1) (Figure 2), Creatine Kinase
(from 96 ± 34 to 67 ± 23 IU·L
-1) (Table 2), and Alpha-1
Antichymotrypsin (from 108.9 ± 38.6 to 55.5 ± 22.2
ug·mL
-1) (Figure 3), whereas women only showed a sig-
nificant decrease in IL-6 post supplementation (from
1.16 ± 0.04 to 0.7 ± 0.4 pg·mL
-1). No differences were
seen for cortisol, C- reactive protein, or brachial artery
FMD (Table 2).
In terms of the perceptual variables, a significant
increase in energy after supplementation was seen for
both men (placebo: 1.8 ± 0.7; supplement: 3.7 ± 0.8
AUC) and women (placebo: 1.2 ± 0.7; supplement: 2.8 ±
0.8 AUC) as shown in Table 3. Women also reported a
lower anxiety level (from 53.0 ± 8.9 to 45.0 ± 8.3 AUC)
that was not seen in men (remained at about 43.0 ± 7.3
AUC). Men showed a significant improvement in fati-
gue, pain, and joint pain after supplementation, which
was not seen in women. No other significant differences
were noted among the perceptual subscales.
The results of performance testing are seen in Table 4.
Men produced significantly higher power during the
countermovement jump (from 2642 ± 244 to 3134 ±
282 W) and greater force in the grip strength test (from
42.1 ± 5.9 to 48.5 ± 4.9 kg) after supplementation.
W o m e nd i dn o ts h o wi m p r o v e dp o w e ro rs t r e n g t h ,b u t
did show a significant improvement in the postural sway
test (from 0.52 ± 0.13 to 0.45 ± 0.12 cm).
Discussion
The primary finding of the current investigation is that a
multi-nutrient supplement improved indices of inflam-
mation and recovery in active, middle-age individuals. In
addition to improved energy in both men and women,
both sexes displayed sex-specific improvements in per-
formance. This suggests that such a supplement may
prolong functionality and physiological performance
with age, thereby permitting individuals to continue to
practice an active lifestyle.
Decreased Inflammatory Status with IL-6
There was a decrease in IL-6 for both men and women
as shown in Figure 2, indicating a decrease in inflamma-
tory status. The normal cortisol, C-reactive protein
levels, and brachial artery reactivity in our study indi-
cated that our population consisted of otherwise healthy
individuals unlikely to have localized inflammatory dis-
orders. Whether through inhibition of IL-1b [29], NF-
kB [32], or other factors, there may be an association
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quercetin, and taurine) and/or BCAA used in this inves-
tigation with the decrease in IL-6. Thus, even in an
otherwise healthy population, the supplement effectively
reduced inflammatory status in both men and women.
While the subjects investigated did not display abnormal
starting concentrations of IL-6, this may have important
implications, as elevated IL-6 concentrations are asso-
ciated with mortality, chronic disease, and other condi-
tions [6]. Future research may help to clarify whether
elevated normal IL-6 in healthy individuals is related to
health outcomes in that population.
Improved Physical Performance in Men
As shown in Figure 3, alpha-1-antichymotrypsin
(ACT) decreased in men but not women; in addition,
vertical jump and grip strength also increased in men
a n dn o tw o m e n .G i v e nt h a tm e nb e g a nt h es t u d yw i t h
slightly higher ACT than women, this may suggest
that the supplement permitted an increase in strength
Figure 2 Interleukin-6 (IL-6). There was a significant decrease in interleukin-6 for both men and women from pre-supplementation, * = P ≤
0.05 from corresponding pre-BioCharge and placebo conditions. Grey: men; white: women.
Table 2 Physiological markers of inflammation in response to supplementation
Men Women
Variables Pre Placebo Post Placebo Pre Suppl Post Suppl Pre Placebo Post Placebo Pre Suppl Post Suppl
M ± SD M ± SD M ± SD M ± SD M ± SD M ± SD M ± SD M ± SD
Creatine Kinase (IU·L
-1) 92 ± 25 80 ± 32 96 ± 34 67 ± 23* 68 ± 42 69 ± 50 66 ± 32 62 ± 33
Cortisol (nmol·L
-1) 557 ± 169 613 ± 128 524 ± 180 515 ± 187 560 ± 149 513 ± 129 518 ± 165 541 ± 148
C-Reactive Protein (mg·dL
-1) 0.22 ± 0.25 0.19 ± 0.25 0.17 ± 0.24 0.19 ± 0.22 0.10 ± 0.10 0.11 ± 0.09 0.1 ± 0.1 0.12 ± 0.11
Brachial Artery Reactivity (mm) 4.6 ± 0.7 4.8 ± 0.7 4.7 ± 0.8 4.9 ± 0.8 3.7 ± 0.6 4.1 ± 0.6 3.8 ± 0.5 4.1 ± 0.5
No significant differences were seen for placebo (either pre/post placebo or as compared to pre-supplementation). Pre Suppl = Pre-Supplementation testing; Post
Suppl = Post-Supplementation testing. *p ≤ 0.05 as compared to supplementation pre-testing.
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of ACT.
Joint function may suggest another rationale for the
improvement in strength and power performance in
men. IL-6 status is associated with joint pain [44] but
joint pain did not decrease in women despite a
decrease in IL-6. On the other hand, it appears that
alpha-1-antichymotrypsin (which did decrease in men
but not women) can serve as a more sensitive marker
t oa r t h r i t i st h a nm e a s u r e ss u c ha sC - R e a c t i v eP r o t e i n
(which did not change in this investigation) [45]. Thus,
whether through decreased inflammation or analgesic
effects of BCAA, both overall pain and joint pain
(which started slightly higher in men than in women)
decreased in men but not in women. Thus the anti-
inflammatory nature of the supplement may have con-
tributed to increased performance by reducing joint
pain.
Figure 3 Alpha-1 Antichymotrypsin. There was a significant decrease in alpha-1 antichymotrypsin for men from pre-supplementation, * = P ≤
0.05 from corresponding pre-BioCharge and placebo conditions. Grey: men; white: women.
Table 3 Perceptual markers in response to supplementation (area under the curve)
Men Women
Variables Pre Placebo Post Placebo Pre Suppl Post Suppl Pre Placebo Post Placebo Pre Suppl Post Suppl
M±S D M±S D M±S D M±S D M±S D M±S D M±S D M±S D
Energy - 1.8 ± 0.7^ - 3.7 ± 0.8* - 1.2 ± 0.7^ - 2.8 ± 0.8*
Anxiety 43 ± 6.3 42 ± 5.6 43 ± 7.2 43 ± 7.4 50 ± 6.5 49 ± 6.5 53 ± 8.9 45 ± 8.3*
Fatigue 44.9 ± 4.6 43.7 ± 4.5 46.9 ± 5 35.8 ± 6.7* 42.4 ± 9 43.3 ± 5.3 43 ± 9.3 43.2 ± 9.5
Joint Pain 1.1 ± 0.3 1.1 ± 0.3 1.2 ± 0.2 0.5 ± 0.3* 0.7 ± 0.2 0.8 ± 0.1 0.7 ± 0.2 0.7 ± 0.2
Pain Intensity 0.8 ± 0.06 1.1 ± 0.08 1.1 ± 0.09 0.6 ± 0.06* 0.8 ± 0.07 0.7 ± 0.08 0.6 ± 0.06 0.6 ± 0.08
Please note (as applicable) that no differences were seen in placebo (either pre/post placebo or as compared to pre-supplementation). Pre Suppl = Pre-
Supplementation testing; Post Suppl = Post-Supplementation testing. *p ≤ 0.05 as compared to supplementation pre-testing; ^p < 0.05 as compared to placebo.
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to reductions in ACT, a decrease in Creatine Kinase
(CK) was seen in men and was not seen in women.
Once again, men began the investigation with higher
CK. The reduced CK has been seen in investigations
with taurine supplementation [46] and amino acid sup-
plementation [47] but only to a limited degree with
plant extracts such as green tea [48]. At the same time,
amino acid supplementation has been shown to improve
strength and power performance [49]. Thus, while the
anti-inflammatory plant extracts appear to have played
an important role in recovery, the amino acids may also
have produced improved performance.
Finally, energy improved in both men and women, but
fatigue only significantly decreased in men. The decrease
in perceived fatigue may have resulted in improved per-
formance. While the increased energy is likely due to
the B Vitamins, other ingredients such as quercetin [50]
cannot be excluded as contributors to this phenomenon.
Thus, the supplementation protocol increased energy in
both men and women, but the decrease in fatigue was
only seen in men and may have influenced their
improved performance on strength and power measures.
Improved Physical Performance in Women
In the present investigation, women (who have a higher
risk of hip fracture than men) displayed improved med-
ial-lateral balance with supplementation. At the same
time, women also displayed a decrease in anxiety that
was not seen in men (the anxiety level for women at
baseline (50th percentile, normalized) was higher than
men, but the anxiety level was similar after supplemen-
tation (45
th percentile for women, 43
rd for men)). Pos-
tural sway is strongly and linearly related to anxiety
[51,52], suggesting that the decreased anxiety may have
improved balance in women. Thus, whether through
reduced anxiety or otherwise, the multi-nutrient supple-
mentation improved balance in women and thereby
reduced a risk factor for falling.
Conclusions
The purpose of the current investigation was to examine
the effects of a multi-nutrient supplement on the
recovery free-living, middle aged individuals from their
active lifestyles in terms of physical performance, fati-
gue, mood, and other factors. As shown, men and
women responded differentially and saw different bene-
fits from the supplement. Inflammation, as determined
by IL-6, clearly showed a benefit in both men and
women. Both men and women reported increased
energy and men displayed a decrease in perceptual fati-
gue. Anxiety decreased in women, which may have
resulted in the decrease women showed in postural
sway. Such an outcome could decrease the risk of hip
fracture in women. Men showed a decrease in alpha-1-
antichymotrypsin, general and joint pain, and an
improvement in physical performance. In all cases, the
supplement helped to fight signs of aging and could act
to prolong the ability of middle-aged individuals to con-
tinue their active lifestyles. It therefore appears that a
multi-nutrient supplement is beneficial to recovery,
inflammatory status, and performance of active men and
women. Given the importance of physical activity itself
in counteracting inflammation and other indices of
aging, this supplement may promote a cycle of anti-
inflammatory activity and anti-aging benefits.
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